All Posts: brain
-
Brain Chemistry Profiles Shows Chronic Fatigue Syndrome and Gulf War Illness as Unique Disorders
Researchers at Georgetown University Medical Center have found distinct molecular signatures in chronic fatigue syndrome and Gulf War Illness, two brain disorders long thought to be psychological in origin.
Category: News Release
-
If Your Child is Bilingual, Learning Additional Languages Later Might be Easier
It is often claimed that bilinguals are better than monolinguals at learning languages. Now, the first study to examine bilingual and monolingual brains as they learn an additional language offers new evidence that supports this hypothesis, researchers say.
Category: News Release
-
Agent Clears Toxic Proteins, Reduces Inflammation and Improves Cognition in Neurodegeneration Models
LONDON (July 16, 2017) — Researchers have found cell receptors abnormally overexpressed in post-mortem brains of those with Parkinson’s and Alzheimer’s diseases, and that they can be inhibited in animal models to clear toxic protein buildup, reduce brain inflammation, and improve cognitive performance. These dual findings, presented by Georgetown University Medical Center (GUMC) researchers at […]
Category: News Release
-
Georgetown University Licenses Use of Tyrosine Kinase Inhibitors for Treatment of Neurodegenerative Diseases
Georgetown University today announces it has exclusively licensed worldwide intellectual property (IP) rights to develop and commercialize uses of tyrosine kinase (TK) inhibitors for the treatment of neurodegenerative diseases to Axovant Sciences GmbH.
Category: News Release
-
Georgetown Clinical Trial Testing Nilotinib in Alzheimer’s Disease Begins
A clinical trial to examine the effect of nilotinib on clinical outcomes and biomarkers in people with mild to moderate Alzheimer’s disease has opened at Georgetown University Medical Center (GUMC).
Category: News Release
-
Steroid Originally Discovered in the Dogfish Shark Attacks Parkinson’s-Related Toxin in Animal Model
A naturally occurring steroid made by the dogfish shark prevents the buildup of a lethal protein in animal studies, reports an international team of researchers. The clustering of this protein, alpha-synuclein (α-synuclein), is the hallmark of Parkinson’s disease and dementia with Lewy bodies, suggesting a new potential compound for therapeutic research.
Category: News Release
-
Volunteers Needed to Evaluate Sesame Street’s Autism Initiative
Parents of children with autism under the age of six are invited to participate in a new study designed to evaluate “Sesame Street and Autism: See Amazing in All Children.” The initiative, developed by Sesame Workshop, is designed to reduce stigma and build understanding about autism spectrum disorder.
Category: News Release
-
Nobel Prize-winning Science is Key to Georgetown Neurotherapeutic Research
Today, the 2016 Nobel Prize in the category of medicine or physiology was awarded to Yoshinori Ohsumi “for his discoveries of mechanisms for autophagy,” a fundamental process for degrading and recycling cellular components.
Category: GUMC Stories
-
Georgetown Receives FDA Clearance to Conduct Clinical Trial with Nilotinib in Alzheimer’s Disease
Georgetown University Medical Center today announces the U.S. Food and Drug Administration has completed its review of an investigational new drug application (IND) for the use of nilotinib in a phase II clinical trial for patients with mild to moderate Alzheimer’s disease.
Category: News Release
-
Resveratrol Appears to Restore Blood-Brain Barrier Integrity in Alzheimer’s Disease
TORONTO (July 27, 2016) — Resveratrol, given to Alzheimer’s patients, appears to restore the integrity of the blood-brain barrier, reducing the ability of harmful immune molecules secreted by immune cells to infiltrate from the body into brain tissues, say researchers at Georgetown University Medical Center. The reduction in neuronal inflammation slowed the cognitive decline of patients, […]
Category: News Release